Navigation Links
Abbott 'Goes Red' to Educate Bay Area Women About Heart Disease
Date:2/1/2008

cise a regular part of my life and has helped repair the damage to my

heart. Through this campaign, I hope other women hear my story and take

steps to understand their risk for heart disease."

Michelle Smietana, of Abbott, 33-year-old heart attack victim

According to AHA, Michelle is not alone. Heart attacks strike 9,000 women younger than 45 each year.

To increase the awareness of this and other little known facts about heart disease, Dr. Sandra Burke, a scientist in the Santa Clara-based vascular division of Abbott, is dedicating her career and her free time to fighting heart disease.

"Abbott and AHA urge women to talk to their doctors about their risk of

heart disease and to start taking action to lead healthier lives."

Dr. Sandra Burke

Director, cardiovascular biology research, Abbott Vascular

In addition to raising awareness through campaigns like "Go Red," Abbott is committed to developing new drugs and medical devices to treat heart disease and related conditions. With diagnostic tests, pharmaceutical products, nutritional products and vascular stents to diagnose and treat heart disease, Abbott has one of the world's leading heart disease and vascular care businesses.

Abbott's CEO, Miles White, sent an e-mail to the company's 35,000 U.S. employees earlier today echoing this commitment.

"Abbott is in the fight against heart disease for the long haul and

through all the means at our disposal: with our diagnostic tests to

identify cardiovascular conditions, our pharmaceutical treatments to

improve patients' cardiovascular health, our nutritional products that

help to improve cardiovascular status, and our stents that relieve acute

vascular conditions by reopening blocked arteries. It's only natural that

we lend our philanthropic support and the skills and commitment of our

people, as well." <
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Abbott to Present at Merrill Lynch Healthcare Conference
2. Abbotts Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA
3. Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2007 Earnings
4. Cookie Johnson and Abbott Bring I Stand With Magic: Campaign to End Black AIDS to Los Angeles to Educate African-American Women on HIV/AIDS
5. Ugandan Children Are Among the First to Receive Abbotts Lower-Strength Aluvia (lopinavir/ritonavir) Tablet
6. The Magic Johnson Foundation and Abbott Expand Focus of Campaign to End Black AIDS to African-American Women in 2008
7. FDA Advisory Committee Recommends Approval of Abbotts XIENCE(TM) V Drug Eluting Stent System
8. Abbotts Environmental Protection Initiatives Again Recognized by the State of Illinois
9. Abbott Employees Give Back to Local Communities This Holiday Season
10. AUDIO from Medialink and Abbott Labs: Easing Holiday Stress for Families of Those With Diabetes
11. Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for Pediatric HIV Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...swire-USNewswire/ -- The American Heart,Associatio... Lewis,Achievement Award, the association,s highes...ard was established in 2000, to recognize and hono...edical journalists who have documented,the conside...ease and,stroke. This career achievement award was...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The Alameda County,P...ly 24-26 at the Oakland,Marriott to address the so...in individuals from low-income and communities of ...s and counties will attend. Place Matters,is a nat... and Economic,Studies, Health Policy Institute and...
(Date:7/23/2008)...e Dangerous for Morbidly Obese Women? ,As the ...are consulting plastic surgeons for breast reducti...ad been thought to have higher complication rates....e as safe to perform large-volume breast reduction...Study title: Breast Reduction: Safe in the Morbidl...
(Date:7/23/2008)...23 /PRNewswire-USNewswire/ -- The New Jersey,Hospi...t Safety has,received a planning grant for $199,50...o develop a proposal for improving the quality of,...termine over the next six months whether New,Jerse... Quality initiative,which is focused on lifting t...
Breaking Medicine News(10 mins):Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2
...came to an abrupt end when a guest discovered bodi... Didier Charrons wife Chantal, 46, and son Bryan ...lping to clear up after a dinner with a group of f...s home in the city of Verviers, 78 miles east of B...
...tion today announced that with the initiation of a...n in Los Angeles, it will accelerate the recruitm...linical study of EPC2407, a novel small molecule v...cer for the treatment of patients with advanced so...
...ies on Thursday reported 38 new cases of the feare... the country's east . The regional authorities in...8 dead birds found on the shores of an artificial ...elbra had all tested positive. Saxony-Anhalt is t...
...ood massage, a bath under a medicinal waterfall, f...f by a good sleep at a comfortable resting place,...certified to have curative qualities by thousands ...tralam regularly. The water that comes down from ...
Other Medicine News:Health News:Dinner Guest Recover Bodies in Freezer 2Health News:EpiCept Accelerates Development of Phase I Clinical Study for Cancer 2
(Date:7/23/2008)...SEATTLE, July 23 /- Sound Pharmaceuti...pplication with the FDA for the clinical,testing o...vention of,chemotherapy induced hearing loss or ot...I-3005, will be tested in advanced stage lung canc...tinum based chemotherapy.,This marks the second de...
(Date:7/23/2008)...SAN FRANCISCO, July 23 /- InCode BioP...company, today announced preclinical test,results ...date rC3-1 for,the treatment of the rare chronic b...(PNH). The complete results will be presented at t..., Switzerland, September 28,2008., The only trea...
(Date:7/22/2008)...- Strong efficacy results from a multi-center 293-...com , Toronto Stock Exchange Symbol: CYT, MONTRE...echnologies,Inc., the global leader in cryotherapy...unced that results previously presented from three...roduct, Arctic Front(R),were published earlier to...
(Date:7/22/2008)...tudy Demonstrates Feasibility and Efficacy of Trea...y Liver Cancer, SAN FRANCISCO, and YONGIN-SI, Sou...San Francisco, CA and Ottawa, Ontario), and its So...day that novel findings from,a Phase I clinical tr...nstrated that the product was well-tolerated and r...
Breaking Medicine Technology:Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4U S Army Selects Cogon Systems to Develop Advanced Clinical Decision Support Tools for Hand Held Computers 5170 1U S Army Selects Cogon Systems to Develop Advanced Clinical Decision Support Tools for Hand Held Computers 5170 2Announcing Always Best Care Senior Services Expansion Into the Littleton Denver Colorado Area 5167 1Announcing Always Best Care Senior Services Expansion Into the Littleton Denver Colorado Area 5167 2Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 1Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 2Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 3Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 4Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 5Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 6Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 7Amicus Therapeutics Announces Third Quarter 2007 Financial Results 1627 8Align Technology Inc Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific 26 Medical Equipment and Bio Technology Com 1624 1Align Technology Inc Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific 26 Medical Equipment and Bio Technology Com 1624 2Align Technology Inc Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific 26 Medical Equipment and Bio Technology Com 1624 3
...(BUSINESS WIRE)--Jul 2, 2007 - Ceragenix Pharmaceu...pany focused on,infectious disease and dermatology...ty of Pennsylvania led by Dr. Paul,Janmey and Dr. ...vage of Brigham Young University, have demonstrate...stigational drug compound known,as CSA-13 shows pr...
...TON, January 29, 2007 /PRNewswire-USNewswire/ -- R...he President,s,Malaria Coordinator, announced his ...ty Coordinator of the President,s Malaria,Initiati...the U.S.,Public Heath Service and has most recentl...ion, at the Global Fund to Fight,AIDS, Tuberculosi...
Other Medicine Technology:Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 2Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 3Ceragenix Compound Shows Promise for Treating Lethal Cystic,Fibrosis Infections 4Studies of Drug Resistance May Lead to Individual Therapy for Rare,Cancers 2
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: